Guideline on the Evaluation of Anticancer Medicinal Products in Man - Methodological Considerations for Using Progression-Free Survival (PFS) as Primary endpoints in confirmatory trials for registration Human
http://www.emea.europa.eu/pdfs/human/ewp/2799408en.pdf
登録:
コメントの投稿 (Atom)
0 件のコメント:
コメントを投稿